Sumitomo Mitsui Ds Asset Management Company, LTD Neurocrine Biosciences Inc Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$9.62 Billion
Q1 2025

A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 11,168 shares of NBIX stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,168

Previous 11,218 0.45%

Holding current value

$1.39 Million

Previous $1.53 Million 19.33%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$107.22 - $153.29 $5,361 - $7,664	-50 Reduced 0.45%	11,168 $1.24 Million
Q3 2024 Oct 17, 2024	SELL	$114.58 - $153.15 $24,978 - $33,386	-218 Reduced 1.91%	11,218 $1.29 Million
Q2 2024 Jul 30, 2024	BUY	$130.86 - $143.19 $11,777 - $12,887	90 Added 0.79%	11,436 $1.57 Million
Q1 2024 May 02, 2024	BUY	$130.4 - $143.74 $306,309 - $337,645	2,349 Added 26.11%	11,346 $1.56 Million
Q4 2023 Feb 01, 2024	BUY	$106.07 - $132.76 $66,611 - $83,373	628 Added 7.5%	8,997 $1.19 Million
Q3 2023 Oct 30, 2023	SELL	$94.02 - $117.1 $1,974 - $2,459	-21 Reduced 0.25%	8,369 $941,000
Q2 2023 Aug 04, 2023	BUY	$89.53 - $104.87 $19,159 - $22,442	214 Added 2.62%	8,390 $791,000
Q4 2022 Jan 26, 2023	BUY	$106.72 - $127.06 $4,909 - $5,844	46 Added 0.57%	8,176 $0
Q3 2022 Oct 19, 2022	BUY	$92.03 - $107.81 $5,613 - $6,576	61 Added 0.76%	8,130 $863,000
Q2 2022 Jul 13, 2022	BUY	$75.79 - $100.07 $162,948 - $215,150	2,150 Added 36.32%	8,069 $787,000
Q1 2022 Apr 19, 2022	SELL	$72.45 - $94.81 $5,288 - $6,921	-73 Reduced 1.22%	5,919 $555,000
Q4 2021 Jan 20, 2022	BUY	$79.65 - $106.22 $117,244 - $156,355	1,472 Added 32.57%	5,992 $510,000
Q3 2021 Oct 15, 2021	SELL	$86.18 - $99.03 $3,533 - $4,060	-41 Reduced 0.9%	4,520 $433,000
Q3 2020 Oct 29, 2020	BUY	$96.16 - $135.15 $1,442 - $2,027	15 Added 0.33%	4,561 $438,000
Q1 2020 Apr 21, 2020	SELL	$75.11 - $113.76 $63,843 - $96,696	-850 Reduced 15.75%	4,546 $393,000
Q4 2019 Jan 24, 2020	BUY	$86.8 - $118.57 $468,372 - $639,803	5,396 New	5,396 $580,000
Q2 2019 Aug 13, 2019	SELL	$72.24 - $91.27 $341,334 - $431,250	-4,725 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$69.31 - $91.53 $327,489 - $432,479	4,725 New	4,725 $416,000

Others Institutions Holding NBIX

# of Institutions

649

Shares Held

97.1M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account

Sumitomo Mitsui Ds Asset Management Company, LTD Neurocrine Biosciences Inc Transaction History